Hongmei Li

机构：Jilin University, First Hospital of Jilin University, Guizhou Provincial People's Hospital · ORCID：0000-0001-8555-8270

发表论文 150 篇 · 总被引 3288 次 · h-index 26

代表论文

• Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer (2023 · Frontiers in Immunology · 被引 25)
• Efficacy and Safety of 225Ac-DOTATATE in the Treatment of Neuroendocrine Neoplasms With High SSTR Expression (2024 · Clinical Nuclear Medicine · 被引 13)
• Therapeutic Targeting of PKM2 Ameliorates NASH Fibrosis Progression in a Macrophage-Specific and Liver-Specific Manner (2024 · Engineering · 被引 10)
• Dexmedetomidine post-treatment exacerbates metabolic disturbances in septic cardiomyopathy via α2A-adrenoceptor (2023 · Biomedicine & Pharmacotherapy · 被引 10)
• Tartary buckwheat protein-derived peptide AFYRW alleviates H2O2-induced vascular injury via the PI3K/AKT/NF-κB pathway (2023 · Prostaglandins & Other Lipid Mediators · 被引 9)
• ENDOGENOUS β3-ADRENERGIC RECEPTOR ACTIVATION ALLEVIATES SEPSIS-INDUCED CARDIOMYOCYTE APOPTOSIS VIA PI3K/AKT SIGNALING PATHWAY (2024 · Shock · 被引 7)